Total Payments
$973.27
2022 Payments
$109.03
Companies
4
Transactions
11
Medicare Patients
749
Medicare Billing
$95,148
Payment Breakdown by Category
Travel$603.74 (62.0%)
Food & Beverage$369.53 (38.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $603.74 | 4 | 62.0% |
| Food and Beverage | $369.53 | 7 | 38.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $782.16 | 8 | $0 (2022) |
| Gilead Sciences, Inc. | $96.66 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $80.36 | 1 | $0 (2017) |
| Alfasigma USA, Inc. | $14.09 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $109.03 | 1 | Boston Scientific Corporation ($109.03) |
| 2021 | $769.79 | 8 | BOSTON SCIENTIFIC CORPORATION ($673.13) |
| 2020 | $14.09 | 1 | Alfasigma USA, Inc. ($14.09) |
| 2017 | $80.36 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($80.36) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/01/2022 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $109.03 | General |
| Category: EXALT_ENDO | ||||||
| 09/28/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL THERAPIES (Device) | Travel and Lodging | Cash or cash equivalent | $255.21 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/28/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL THERAPIES (Device) | Travel and Lodging | Cash or cash equivalent | $84.72 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/28/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL THERAPIES (Device) | Food and Beverage | Cash or cash equivalent | $10.24 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/11/2021 | BOSTON SCIENTIFIC CORPORATION | EXALT (Device) | Food and Beverage | In-kind items and services | $51.25 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/10/2021 | BOSTON SCIENTIFIC CORPORATION | EXALT (Device) | Travel and Lodging | In-kind items and services | $144.55 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/09/2021 | BOSTON SCIENTIFIC CORPORATION | EXALT (Device) | Travel and Lodging | In-kind items and services | $119.26 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/09/2021 | BOSTON SCIENTIFIC CORPORATION | EXALT (Device) | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/12/2021 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $96.66 | General |
| Category: HCV | ||||||
| 01/29/2020 | Alfasigma USA, Inc. | — | Food and Beverage | In-kind items and services | $14.09 | General |
| 11/16/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $80.36 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 337 | 347 | $391,739 | $44,973 |
| 2022 | 10 | 345 | 364 | $377,560 | $42,688 |
| 2021 | 4 | 67 | 68 | $77,806 | $7,487 |
Total Patients
749
Total Services
779
Medicare Billing
$95,148
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 116 | 116 | $166,924 | $22,746 | 13.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 44 | 44 | $61,116 | $3,574 | 5.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 19 | 19 | $20,423 | $3,191 | 15.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 49 | 50 | $60,300 | $3,177 | 5.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 17 | 17 | $18,258 | $2,929 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 37 | $14,615 | $2,732 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $10,220 | $2,537 | 24.8% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 15 | 15 | $19,545 | $1,685 | 8.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $5,330 | $1,286 | 24.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $15,008 | $1,116 | 7.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 91 | 94 | $135,266 | $17,328 | 12.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 65 | 73 | $88,038 | $5,168 | 5.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $18,907 | $4,384 | 23.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 36 | 36 | $14,760 | $3,584 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 32 | $12,640 | $2,727 | 21.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 37 | 38 | $52,782 | $2,428 | 4.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $16,110 | $2,026 | 12.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 12 | 12 | $12,900 | $2,015 | 15.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 15 | 15 | $19,545 | $1,543 | 7.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 12 | $6,612 | $1,485 | 22.5% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 23 | 23 | $33,097 | $4,123 | 12.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 15 | $6,150 | $1,568 | 25.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 16 | 17 | $20,502 | $1,206 | 5.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 13 | 13 | $18,057 | $591.12 | 3.3% |
About Dr. Jonathan Hattenhauer, D.O
Dr. Jonathan Hattenhauer, D.O is a Gastroenterology healthcare provider based in Milwaukie, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2015. The National Provider Identifier (NPI) number assigned to this provider is 1013302348.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Hattenhauer, D.O has received a total of $973.27 in payments from pharmaceutical and medical device companies, with $109.03 received in 2022. These payments were reported across 11 transactions from 4 companies. The most common payment nature is "Travel and Lodging" ($603.74).
As a Medicare-enrolled provider, Hattenhauer has provided services to 749 Medicare beneficiaries, totaling 779 services with total Medicare billing of $95,148. Data is available for 3 years (2021–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Milwaukie, OR
- Active Since 04/03/2015
- Last Updated 08/19/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1013302348
Products in Payments
- GENERAL THERAPIES (Device) $350.17
- EXALT (Device) $322.96
- EXALT Model D (Device) $109.03
- Epclusa (Drug) $96.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.